Craniometaphyseal dysplasia with increased bone turnover and secondary hyperparathyroidism: Therapeutic effect of calcitonin
- 30 April 1988
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 112 (4) , 587-591
- https://doi.org/10.1016/s0022-3476(88)80176-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Diagnostic Evaluation of Measurements of Carboxyl-Terminal Flanking Peptide (PDN-21) of the Human Calcitonin Gene in Human Serum*Journal of Clinical Endocrinology & Metabolism, 1985
- A Microassay for 1,25-Dihydroxyvitamin D Not requiring High Performance Liquid Chromatography: Application to Clinical Studies*Journal of Clinical Endocrinology & Metabolism, 1984
- Dissociation of Parathyroid Hormone Bioactivity and Immunoreactivity in Pseudohypoparathyroidism Type I*Journal of Clinical Endocrinology & Metabolism, 1981
- Familial hyperphosphatasemia: diagnosis in early infancy and response to human thyrocalcitonin therapyAmerican Journal of Roentgenology, 1979
- Craniometaphyseal dysplasia ‐variability of expression within a large familyClinical Genetics, 1979
- Cranial Metaphyseal Dysplasia: Otolaryngologic AspectsJAMA Otolaryngology–Head & Neck Surgery, 1973
- Craniometaphyseal dysplasia congenita—Pyle's disease in a young childThe British Journal of Radiology, 1969
- Craniofacial surgery in craniometaphyseal dysplasiaThe American Journal of Surgery, 1967
- A rare case of bone dystrophyBritish Journal of Surgery, 1949